FEDERATED HERMES, INC. - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,133
-100.0%
25
-100.0%
0.00%
-100.0%
Q3 2022$18,177,000
+2.1%
260,270
-1.8%
0.05%
+10.4%
Q2 2022$17,800,000
-16.5%
265,156
+2.3%
0.05%0.0%
Q1 2022$21,312,000
-43.9%
259,207
+0.1%
0.05%
-32.4%
Q4 2021$37,971,000
+38.1%
258,848
+66.6%
0.07%
+36.5%
Q3 2021$27,492,000
+10.0%
155,400
+0.5%
0.05%
+10.6%
Q2 2021$24,989,000
-7.0%
154,700
-1.4%
0.05%
-9.6%
Q1 2021$26,866,000
-49.4%
156,839
-35.2%
0.05%
-52.3%
Q4 2020$53,142,000
+51.2%
241,952
+14.3%
0.11%
+32.9%
Q3 2020$35,150,000
+73.0%
211,685
+19.0%
0.08%
+64.0%
Q2 2020$20,317,000
+1650.0%
177,950
+1078.4%
0.05%
+1566.7%
Q1 2020$1,161,000
+171.3%
15,101
+355.0%
0.00%
+200.0%
Q4 2019$428,000
-85.8%
3,319
-91.4%
0.00%
-85.7%
Q3 2019$3,005,000
-70.8%
38,564
-61.5%
0.01%
-72.0%
Q2 2019$10,305,000
-6.0%
100,044
-33.1%
0.02%
-7.4%
Q1 2019$10,960,000
+230.1%
149,527
+91.0%
0.03%
+200.0%
Q4 2018$3,320,000
-41.4%
78,272
-34.9%
0.01%
-30.8%
Q3 2018$5,667,000
+237.1%
120,317
+252.8%
0.01%
+160.0%
Q2 2018$1,681,000
+1193.1%
34,099
+707.3%
0.01%
Q1 2018$130,000
-32.6%
4,224
-60.0%
0.00%
-100.0%
Q4 2017$193,000
-15.7%
10,568
-46.0%
0.00%0.0%
Q3 2017$229,000
+209.5%
19,569
-3.3%
0.00%
Q2 2017$74,000
+1750.0%
20,247
+2363.1%
0.00%
Q1 2017$4,000
-33.3%
822
-39.0%
0.00%
Q4 2016$6,000
-33.3%
1,348
+326.6%
0.00%
Q1 2015$9,0003160.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders